Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 14, 2025; 31(10): 102393
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.102393
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.102393
Table 3 Tumour characteristics of recurrence
| Patient | Location | Size, cm | Mitotic rates | Growth pattern | Margin status | Classification of tumour | Connection to MP layer | Follow-up time, months | Imatinib time, months | Reoperation | Survive |
| 1 | Middle | 7 | 1 | Extraluminal | R1 | High risk | Yes | 33 | No | No | Yes |
| 2 | Lower | 2 | 0 | Intraluminal | R0 | Very low risk | Yes | 107 | No | No | Yes |
| 3 | Lower | 1 | 7 | Intraluminal | R0 | Low risk | Yes | 40 | No | No | Yes |
- Citation: Xu EP, Qi ZP, Zhang JW, Li B, Ren Z, Cai MY, Cai SL, Lv ZT, Chen ZH, Liu JY, Zhong YS, Zhou PH, Shi Q. Endoscopic treatment outcome of oesophageal gastrointestinal stromal tumours. World J Gastroenterol 2025; 31(10): 102393
- URL: https://www.wjgnet.com/1007-9327/full/v31/i10/102393.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i10.102393